• Je něco špatně v tomto záznamu ?

DNA Methylation Status in Cancer Disease: Modulations by Plant-Derived Natural Compounds and Dietary Interventions

K. Jasek, P. Kubatka, M. Samec, A. Liskova, K. Smejkal, D. Vybohova, O. Bugos, K. Biskupska-Bodova, T. Bielik, P. Zubor, J. Danko, M. Adamkov, TK. Kwon, D. Büsselberg,

. 2019 ; 9 (7) : . [pub] 20190718

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články, práce podpořená grantem, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc20023819

The modulation of the activity of DNA methyltransferases (DNMTs) represents a crucial epigenetic mechanism affecting gene expressions or DNA repair mechanisms in the cells. Aberrant modifications in the function of DNMTs are a fundamental event and part of the pathogenesis of human cancer. Phytochemicals, which are biosynthesized in plants in the form of secondary metabolites, represent an important source of biomolecules with pleiotropic effects and thus provide a wide range of possible clinical applications. It is well documented that phytochemicals demonstrate significant anticancer properties, and in this regard, rapid development within preclinical research is encouraging. Phytochemicals affect several epigenetic molecular mechanisms, including DNA methylation patterns such as the hypermethylation of tumor-suppressor genes and the global hypomethylation of oncogenes, that are specific cellular signs of cancer development and progression. This review will focus on the latest achievements in using plant-derived compounds and plant-based diets targeting epigenetic regulators and modulators of gene transcription in preclinical and clinical research in order to generate novel anticancer drugs as sensitizers for conventional therapy or compounds suitable for the chemoprevention clinical setting in at-risk individuals. In conclusion, indisputable anticancer activities of dietary phytochemicals linked with proper regulation of DNA methylation status have been described. However, precisely designed and well-controlled clinical studies are needed to confirm their beneficial epigenetic effects after long-term consumption in humans.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20023819
003      
CZ-PrNML
005      
20210219151642.0
007      
ta
008      
201125s2019 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/biom9070289 $2 doi
035    __
$a (PubMed)31323834
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Jasek, Karin $u Division of Oncology, Biomedical Center Martin, Jessenius Faculty of Medicine, Comenius University in Bratislava, 036 01 Martin, Slovakia.
245    10
$a DNA Methylation Status in Cancer Disease: Modulations by Plant-Derived Natural Compounds and Dietary Interventions / $c K. Jasek, P. Kubatka, M. Samec, A. Liskova, K. Smejkal, D. Vybohova, O. Bugos, K. Biskupska-Bodova, T. Bielik, P. Zubor, J. Danko, M. Adamkov, TK. Kwon, D. Büsselberg,
520    9_
$a The modulation of the activity of DNA methyltransferases (DNMTs) represents a crucial epigenetic mechanism affecting gene expressions or DNA repair mechanisms in the cells. Aberrant modifications in the function of DNMTs are a fundamental event and part of the pathogenesis of human cancer. Phytochemicals, which are biosynthesized in plants in the form of secondary metabolites, represent an important source of biomolecules with pleiotropic effects and thus provide a wide range of possible clinical applications. It is well documented that phytochemicals demonstrate significant anticancer properties, and in this regard, rapid development within preclinical research is encouraging. Phytochemicals affect several epigenetic molecular mechanisms, including DNA methylation patterns such as the hypermethylation of tumor-suppressor genes and the global hypomethylation of oncogenes, that are specific cellular signs of cancer development and progression. This review will focus on the latest achievements in using plant-derived compounds and plant-based diets targeting epigenetic regulators and modulators of gene transcription in preclinical and clinical research in order to generate novel anticancer drugs as sensitizers for conventional therapy or compounds suitable for the chemoprevention clinical setting in at-risk individuals. In conclusion, indisputable anticancer activities of dietary phytochemicals linked with proper regulation of DNA methylation status have been described. However, precisely designed and well-controlled clinical studies are needed to confirm their beneficial epigenetic effects after long-term consumption in humans.
650    _2
$a protinádorové látky $x farmakologie $7 D000970
650    _2
$a metylace DNA $x účinky léků $7 D019175
650    _2
$a epigeneze genetická $x genetika $7 D044127
650    _2
$a lidé $7 D006801
650    _2
$a nádory $x genetika $7 D009369
650    _2
$a fytonutrienty $x farmakologie $7 D064209
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
655    _2
$a přehledy $7 D016454
700    1_
$a Kubatka, Peter $u Department of Medical Biology, Jessenius Faculty of Medicine, Comenius University in Bratislava, 036 01 Martin, Slovakia. peter.kubatka@uniba.sk. Division of Oncology, Biomedical Center Martin, Jessenius Faculty of Medicine, Comenius University in Bratislava, 036 01 Martin, Slovakia. peter.kubatka@uniba.sk.
700    1_
$a Samec, Marek $u Department of Obstetrics and Gynecology, Jessenius Faculty of Medicine, Comenius University in Bratislava, 036 01 Martin, Slovakia.
700    1_
$a Liskova, Alena $u Department of Obstetrics and Gynecology, Jessenius Faculty of Medicine, Comenius University in Bratislava, 036 01 Martin, Slovakia.
700    1_
$a Smejkal, Karel $u Department of Natural Drugs, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences, 612 42 Brno, Czech Republic.
700    1_
$a Vybohova, Desanka $u Department of Anatomy, Jessenius Faculty of Medicine, Comenius University in Bratislava, 036 01 Martin, Slovakia.
700    1_
$a Bugos, Ondrej $u Lambda Life JSC., 851 01 Bratislava, Slovakia.
700    1_
$a Biskupska-Bodova, Kristina $u Department of Obstetrics and Gynecology, Jessenius Faculty of Medicine, Comenius University in Bratislava, 036 01 Martin, Slovakia.
700    1_
$a Bielik, Tibor $u Department of Obstetrics and Gynecology, Jessenius Faculty of Medicine, Comenius University in Bratislava, 036 01 Martin, Slovakia.
700    1_
$a Žúbor, Pavol, $d 1975- $u Department of Obstetrics and Gynecology, Jessenius Faculty of Medicine, Comenius University in Bratislava, 036 01 Martin, Slovakia. $7 xx0117542
700    1_
$a Danko, Jan $u Department of Obstetrics and Gynecology, Jessenius Faculty of Medicine, Comenius University in Bratislava, 036 01 Martin, Slovakia.
700    1_
$a Adamkov, Marian $u Department of Histology and Embryology, Jessenius Faculty of Medicine, Comenius University in Bratislava, 036 01 Martin, Slovakia.
700    1_
$a Kwon, Taeg Kyu $u Department of Immunology, School of Medicine, Keimyung University, Dalseo-Gu, Daegu 426 01, Korea.
700    1_
$a Büsselberg, Dietrich $u Weill Cornell Medicine in Qatar, Qatar Foundation-Education City, Doha 24144, Qatar. dib2015@qatar-med.cornell.edu.
773    0_
$w MED00188737 $t Biomolecules $x 2218-273X $g Roč. 9, č. 7 (2019)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31323834 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20201125 $b ABA008
991    __
$a 20210219151640 $b ABA008
999    __
$a ok $b bmc $g 1596138 $s 1114495
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 9 $c 7 $e 20190718 $i 2218-273X $m Biomolecules $n Biomolecules $x MED00188737
LZP    __
$a Pubmed-20201125

Najít záznam

Citační ukazatele

Možnosti archivace